SCALA: a Randomized Phase I Trial Comparing Subcutaneous and Intravenous Alemtuzumab in Patients with Progressive Multiple Sclerosis
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS（2024）
关键词
alemtuzumab,Expanded Disability Status Scale,leukocytes,lymphocytes,multiple sclerosis,progressive multiple sclerosis
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要